Thai Patent Authorities Await U.S. Compulsory Licensing Challenge Before WTO
This article was originally published in PharmAsia News
Executive Summary
Thailand's patent authorities say they are bracing for a suit they expect to be filed by the United States before the World Trade Organization over the pharmaceutical compulsory-license dispute. A senior official of the Commerce Ministry says America is preparing a suit that alleges Thailand never discussed with patent holders its plan to abrogate drug patents so generic versions of certain drugs could be sold in the country. Thai officials dispute that claim, saying the government had negotiated with patent owners before compulsory licenses were announced. Drug makers offered only to lower their prices gradually. (Click here for more
You may also be interested in...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.